NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球免疫血液學市場:2020年∼2024年

Global Immunohematology Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 979877
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
全球免疫血液學市場:2020年∼2024年 Global Immunohematology Market 2020-2024
出版日期: 2020年12月17日內容資訊: 英文 120 Pages
簡介

全球免疫血液學市場規模在2020年∼2024年間,預測將成長到8億4680萬美元,在預測期間內預計將以8%的年複合成長率增長。

市場成長的主要因素有對血庫的需求及其潛在增長潛力,通過服務導向的銷售組織和GPO帶來的銷售增長以及轉變到最終用戶自動免疫血液分析儀的趨勢。

本報告提供全球免疫血液學市場調查,提供市場形勢和規模,波特的五力分析,各產品及各應用領域等的市場區隔,客戶和各地區形勢,業者情勢,供應商分析等資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年∼2024年的預測

波特的五力分析

市場區隔:各產品

  • 市場區隔
  • 各產品比較
  • 分析設備和系統:市場規模與預測(2019年∼2024年)
  • 試劑:市場規模與預測(2019年∼2024年)
  • 各產品的市場機會

市場區隔:各應用領域

  • 血液相關疾病
  • HIV
  • 肝炎

市場區隔:各終端用戶

  • 醫院
  • 血庫
  • 臨床檢驗室

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美:市場規模與預測(2019年∼2024年)
  • 歐洲:市場規模與預測(2019年∼2024年)
  • 亞洲:市場規模與預測(2019年∼2024年)
  • 其他地區:市場規模與預測(2019年∼2024年)
  • 主要國家
  • 各地區的市場機會
  • 市場推動因素
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況
  • 競爭模式

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Bio-Rad Laboratories Inc.
  • Cardinal Health Inc.
  • CSL Ltd.
  • Danaher Corp.
  • Grifols SA
  • Immucor Inc.
  • Merck KGaA
  • Ortho-Clinical Diagnostics Inc.
  • Siemens Healthineers AG

附錄

目錄
Product Code: IRTNTR45886

Technavio has been monitoring the immunohematology market and it is poised to grow by $ 846.80 mn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our report on immunohematology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for blood banks and its potential to increase sales, increasing sales through service-oriented sales organizations and GPOs, and the paradigm shift of end-users toward automated immunohematology analyzer. In addition, growing demand for blood banks and its potential to increase sales is anticipated to boost the growth of the market as well.

The immunohematology market analysis includes product segment, application segment, end-user segment and geographical landscapes.

Technavio's immunohematology market is segmented as below:

By Product

  • Analyzers And Systems
  • Reagents

By Application

  • Blood-Related Diseases
  • Hiv
  • Hepatitis

By End-user

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the paradigm shift toward molecular immunohematology as one of the prime reasons driving the immunohematology market growth during the next few years. Also, public and private partnerships to establish blood banks and striving market growth through education and training program will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on immunohematology market covers the following areas:

  • Immunohematology market sizing
  • Immunohematology market forecast
  • Immunohematology market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunohematology market vendors that include Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Cardinal Health Inc., CSL Ltd., Danaher Corp., Grifols SA, Immucor Inc., Merck KGaA, Ortho-Clinical Diagnostics Inc., and Siemens Healthineers AG. Also, the immunohematology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Analyzers and systems - Market size and forecast 2019-2024
  • Reagents - Market size and forecast 2019-2024
  • Market opportunity by Product

Market Segmentation by Application

  • Blood-related diseases
  • HIV
  • Hepatitis

Market Segmentation by End-user

  • Hospitals
  • Blood banks
  • Diagnostic laboratories

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bio-Rad Laboratories Inc.
  • Cardinal Health Inc.
  • CSL Ltd.
  • Danaher Corp.
  • Grifols SA
  • Immucor Inc.
  • Merck KGaA
  • Ortho-Clinical Diagnostics Inc.
  • Siemens Healthineers AG

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Product - Market share 2019-2024 (%)
  • 22: Comparison by Product
  • 23: Analyzers and systems - Market size and forecast 2019-2024 ($ million)
  • 24: Analyzers and systems - Year-over-year growth 2019-2024 (%)
  • 25: Reagents - Market size and forecast 2019-2024 ($ million)
  • 26: Reagents - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: Asia - Market size and forecast 2019-2024 ($ million)
  • 36: Asia - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Becton, Dickinson and Co. - Overview
  • 48: Becton, Dickinson and Co. - Business segments
  • 49: Becton, Dickinson and Co. - Key offerings
  • 50: Becton, Dickinson and Co. - Key customers
  • 51: Becton, Dickinson and Co. - Segment focus
  • 52: Bio-Rad Laboratories Inc. - Overview
  • 53: Bio-Rad Laboratories Inc. - Business segments
  • 54: Bio-Rad Laboratories Inc. - Key offerings
  • 55: Bio-Rad Laboratories Inc. - Key customers
  • 56: Bio-Rad Laboratories Inc. - Segment focus
  • 57: Cardinal Health Inc. - Overview
  • 58: Cardinal Health Inc. - Business segments
  • 59: Cardinal Health Inc. - Key offerings
  • 60: Cardinal Health Inc. - Key customers
  • 61: Cardinal Health Inc. - Segment focus
  • 62: CSL Ltd. - Overview
  • 63: CSL Ltd. - Business segments
  • 64: CSL Ltd. - Key offerings
  • 65: CSL Ltd. - Key customers
  • 66: CSL Ltd. - Segment focus
  • 67: Danaher Corp. - Overview
  • 68: Danaher Corp. - Business segments
  • 69: Danaher Corp. - Key offerings
  • 70: Danaher Corp. - Key customers
  • 71: Danaher Corp. - Segment focus
  • 72: Grifols SA - Overview
  • 73: Grifols SA - Business segments
  • 74: Grifols SA - Key offerings
  • 75: Grifols SA - Key customers
  • 76: Grifols SA - Segment focus
  • 77: Immucor Inc. - Overview
  • 78: Immucor Inc. - Product and service
  • 79: Immucor Inc. - Key offerings
  • 80: Immucor Inc. - Key customers
  • 81: Immucor Inc. - Segment focus
  • 82: Merck KGaA - Overview
  • 83: Merck KGaA - Business segments
  • 84: Merck KGaA - Key offerings
  • 85: Merck KGaA - Key customers
  • 86: Merck KGaA - Segment focus
  • 87: Ortho-Clinical Diagnostics Inc. - Overview
  • 88: Ortho-Clinical Diagnostics Inc. - Product and service
  • 89: Ortho-Clinical Diagnostics Inc. - Key offerings
  • 90: Ortho-Clinical Diagnostics Inc. - Key customers
  • 91: Ortho-Clinical Diagnostics Inc. - Segment focus
  • 92: Siemens Healthineers AG - Overview
  • 93: Siemens Healthineers AG - Business segments
  • 94: Siemens Healthineers AG - Key offerings
  • 95: Siemens Healthineers AG - Key customers
  • 96: Siemens Healthineers AG - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations